Modular Synthesis of Diverse Natural Product-like Macrocycles:Discovery of Hits with Antimycobacterial Activity by Dow, Mark et al.
 
 
Modular Synthesis of Diverse Natural Product-like
Macrocycles
Dow, Mark; Marchetti, Fransceco; Abrahams, Katherine; Vaz, Luis; Besra, Gurdyal; Warriner,
Stuart
DOI:
10.1002/chem.201701150
License:
None: All rights reserved
Document Version
Peer reviewed version
Citation for published version (Harvard):
Dow, M, Marchetti, F, Abrahams, K, Vaz, L, Besra, G & Warriner, S 2017, 'Modular Synthesis of Diverse Natural
Product-like Macrocycles: Discovery of Hits with Antimycobacterial Activity', Chemistry: A European Journal.
https://doi.org/10.1002/chem.201701150
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
Checked for eligibility: 10/04/2017.
This is the peer reviewed version of the following article:Dow, M., Marchetti, F., Abrahams, K., Vaz, L., Besra, G., Warriner, S. and Nelson,
A. (2017), Modular Synthesis of Diverse Natural Product-like Macrocycles: Discovery of Hits with Antimycobacterial Activity. Chem. Eur. J.,
which has been published in final form at doi:10.1002/chem.201701150. This article may be used for non-commercial purposes in
accordance with Wiley Terms and Conditions for Self-Archiving.
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Feb. 2019
Supported by
A Journal of
Accepted Article
Title: Modular Synthesis of Diverse Natural Product-like Macrocycles:
Discovery of Hits with Antimycobacterial Activity
Authors: Mark Dow, Fransceco Marchetti, Katherine Abrahams, Luis
Vaz, Gurdyal Besra, stuart warriner, and Adam Nelson
This manuscript has been accepted after peer review and appears as an
Accepted Article online prior to editing, proofing, and formal publication
of the final Version of Record (VoR). This work is currently citable by
using the Digital Object Identifier (DOI) given below. The VoR will be
published online in Early View as soon as possible and may be different
to this Accepted Article as a result of editing. Readers should obtain
the VoR from the journal website shown below when it is published
to ensure accuracy of information. The authors are responsible for the
content of this Accepted Article.
To be cited as: Chem. Eur. J. 10.1002/chem.201701150
Link to VoR: http://dx.doi.org/10.1002/chem.201701150
COMMUNICATION          
 
 
 
 
Modular Synthesis of Diverse Natural Product-like Macrocycles: 
Discovery of Hits with Antimycobacterial Activity 
Mark Dow,[a,b] Francesco Marchetti,[a,b] Katherine A. Abrahams,[c] Luis Vaz,[d] Gurdyal S. Besra,[c] Stuart 
Warriner[a,b] and Adam Nelson*[a,b] 
Abstract: A modular synthetic approach was developed in which 
variation of the triplets of building blocks used enabled systematic 
variation of the macrocyclic scaffolds prepared.  The approach was 
demonstrated in the synthesis of 17 diverse natural product-like 
macrocyclic scaffolds of varied (12-20-membered) ring size.  The 
biological relevance of the chemical space explored was 
demonstrated through the discovery of a series of macrocycles with 
significant antimycobacterial activity. 
The remarkable biological functions of macrocyclic natural 
products have inspired over 100 marketed drugs, predominantly 
based on macrocyclic peptides and macrolides.[1,2]  Yet, despite 
an increasing recognition of their virtues, macrocycles remain an 
under-represented compound class in drug discovery.[3]  
Macrocycles strike a valuable balance between structural pre-
organization, and the flexibility that is needed to target some 
challenging binding sites.[1]  In addition, macrocyclisation can 
increase potency and selectivity dramatically, and improve 
physiochemical and pharmacokinetic properties.[1,2,4]  
Furthermore, an understanding of molecular properties pertinent 
to macrocyclic drug discovery is emerging, together with the 
determinants of cell permeability.[2,5]  Although macrocycles that 
target extended binding sites (e.g. in viral proteases and 
polymerases) typically lie outside conventional drug-like 
chemical space, some bioactive macrocycles (e.g. some kinase 
inhibitors) can have similar properties to other small molecule 
drugs.[2] 
The discovery of bioactive macrocycles has been hampered 
by the historic uneven and unsystematic exploration of the 
relevant chemical space.[6]  As a result, there is a paucity of 
macrocycles in established small molecule screening collections.  
Recently, approaches[7] have been developed for the synthesis 
of diverse non-peptidic macrocycles, for example from building 
blocks,[8] by ring expansion,[9] and using DNA-templated 
methods.[10] In addition, genetically-encoded approaches can 
enable discovery of bioactive macrocyclic peptides.[11]  The 
value of approaches to explore the properties of diverse 
macrocycles is reflected in the discovery of macrocyclic 
antimalarials,[12] angiogenesis inhibitors,[13] histone deacetylase 
inhibitors[14] and blockers of sonic hedgehog signalling.[15] 
   
Scheme 1. Envisaged approach to skeletally-diverse macrocycles. FDIPES, 
diisopropyl (3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)silyl; Ns, 
o-nitro phenylsulfonyl. 
Figure 1. Structures of building blocks. Panel A: Initiating building blocks.  
Panel B: Propagating building blocks.  Panel C: Terminating building blocks.  
Ar, 2,4-dimethoxyphenyl. 
Previously, we reported the diversity-oriented synthesis of 
natural product-like molecules based on >80 diverse molecular 
scaffolds.[16]  Here, the product scaffolds depended on both the 
order and nature of the attachment of pairs of building blocks to 
a fluorous-tagged linker.  We envisaged that the exploitation of 
triplets of building blocks would enable extension to the 
synthesis of skeletally-diverse macrocycles (Scheme 1).  Thus, 
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iterative attachment of propagating and terminating building 
blocks (Figure 1) to a fluorous-tagged initiating building block 1 
( 2) would be followed by macrocyclisation ( 3).  We 
recognised that the fluoroussolid phase extraction[17] (FSPE) 
could enable removal of excess reactants at each stage of the 
synthesis, and facilitate decoration of the product macrocycle. 
Initially, propagating building blocks were attached to the 
fluorous-tagged initiating building blocks 1, 4 and ent-4, followed 
by deacetylation (Scheme 2).  In each case, the fluorous-tagged 
products (13-17) were isolated after F-SPE.   
                          
Scheme 2. Attachment of propagating building blocks to fluorous-tagged 
initiating building blocks.  Methods: A: PPh3, DEAD, THF then F-SPE; B: NH3 
in MeOH. aMass recovery (and purity determined by 500 MHz 1H NMR 
spectroscopy) after purification by F-SPE alone.   
Next, we determined the competence of alternative classes 
of terminating building block.  Thus, the N-o-nitrophenylsulfonyl 
amide 8, the N-o-nitrophenylsulfonyl carbamate 9 and the  
trifluoromethanesulfonamide 11 were appended to appropriate 
substrates (13, 15 and 17) (Scheme 3). The ring-closing 
metatheses[18] of the dienes 2 and 18 (5 mM) proceeded 
smoothly with HoveydaGrubbs second generation catalyst in 
methyl tert-butyl ether (MTBE) at 55 C to give the 
corresponding macrocycles 3 and 19.  However, the clean ring-
closing metathesis of 20 required 10 mol% 1,4-benzoquinone[18b]  
in addition to 5 mol% catalyst to give, after treatment with 
thiophenol and potassium carbonate, the macrocyclic carbamate 
21 (R1=FDIPES; R2=R3=H) in 34% yield.  In a similar vein, 
treatment of the diene 22 with 2 mol% catalyst and 4 mol% 1,4-
benzoquinone gave the corresponding macrocycle 23 
(R1=FDIPES; R2=R3=H) in 84% yield. 
We then investigated the deprotection of the exemplar 
macrocycles.  The attempted deprotection of the macrocycle 3 
did not proceed smoothly.  Treatment of 3 with thiophenol and 
potassium carbonate, followed by FSPE eluting with 
MeOHwater and then methanol, resulted in overall 
methanolysis of the macrolactam; presumably, the Ns group 
promotes thiolysis of the macrolactam to give a thioester which 
is subsequently methanolised.   This unwanted reaction did not 
plague the deprotection of the corresponding diene 2, nor the 
larger macrolactam 19, and may be attributed to the strain of the 
macrocyclic ring system of 3.  In contrast, desulfonylation of the 
macrocycles 21 and 23 proceeded smoothly.  It was decided 
that N-o-nitrophenylsulfonyl amides would not be exploited as 
terminating building blocks in the synthesis of the macrocycle 
library. 
Scheme 3.  Attachment of terminating building blocks and subsequent ring-
closing metathesis.  Methods: A: PPh3, DEAD, CH2Cl2 then F-SPE; C: 1 mol% 
Hoveyda-Grubbs second generation catalyst, MTBE, 55 C then P(CH2OH)3, 
Et3N, silica; D: PhSH, K2CO3, DMF.  aMass recovery (and purity determined by 
500 MHz 1H NMR spectroscopy) after purification by F-SPE alone.  b2 mol% 
catalyst was used.  c5 mol% catalyst and 10 mol% 1,4-benzoquinone was 
used. d2 mol% catalyst and 4 mol% 1,4-benzoquinone was used.  Ar, 2,4-
dimethoxyphenyl.  
The synthesis of a wide range of macrocyclic scaffolds is 
summarised in Table 1 and Figure 2.  The cyclisation precursors 
were prepared by treatment of a fluorous-tagged substrate (13-
17) and a terminating building block (9, 10, 11 or 12) with 
triphenylphosphine and DEAD: the fluorous-tagged product was 
generally purified by FSPE and used without further 
purification.  The cyclisation precursors were treated with 
Hoveyda-Grubbs second generation catalyst (typically 2 mol%), 
usually in the presence of 1,4-benzoquinone.  In general, the 
cyclisation reactions proceeded smoothly, and macrocyclic 
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products were isolated after column chromatography.  The 
stereoselectivity of the metathesis reaction was often high, and, 
in many other cases, the geometric isomers were separable 
after subsequent desulfonylation.  
     
 
Figure 2. Structures of the natural product-like macrocycles prepared by ring-closing metathesis (R1=FDIPES; R2=R3=Ns) (see Table 1 for details).   Subsequently, 
the products were deprotected and decorated to give final compounds (R1=R3=H; R2 = H, cyclopropylcarbonyl, 1-methyl-imidazol-4-yl sulfonyl or 3-
pyridylaminocarbonyl). 
Crucially, it was demonstrated that a modular synthesis 
of macrocyclic scaffolds was possible.  By variation of the 
building blocks used, 17 different macrocyclic scaffolds 
were prepared with ring sizes varying from 12 to 20.  The 
distributions of macrocycle ring sizes and natural product 
likeness scores[19] of the deprotected scaffolds were 
compared with those of 2435 commercially-available[20] 12- 
to 20-membered macrocycles (Figure 3).  The 17 
macrocyclic scaffolds all had positive natural product-
likeness scores that reflect their local natural product-like 
structural features. 
The macrocyclic scaffolds were subsequently 
deprotected and decorated (see Scheme 4 for an 
example).  For example, the macrocycle 32 (R1 = FDIPES; 
R2 = R3 = Ns) was treated with thiophenol and potassium 
carbonate in DMF, and the resulting product was purified 
by F-SPE.  The product was then desilylated ( 39c), or 
decorated prior to desilylation (e.g.  39a or 39b).  In total, 
66 products based on the 17 macrocyclic scaffolds were 
prepared. 
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Table 1. Synthesis of natural product-like macrocycles (see Figure 2; 
Products had R1=FDIPES; R2, R3 = Ns; R4 = TBS unless stated).   
Building 
blocks 
Attachment of terminating 
building block[a] 
Metathesis[c] 
 Mass recovery (purity)[b] Product Yield[d] E:Z[e] 
13, 9 66 (95) 24[f] 33[g] 60:40 
13, 10 77 (93)  25[h] 56 65:35 
13, 11 57[d] 23[f] 84[g] 30:70 
13, 12 93 (>95)  26 76 >98:<2 
14, 9 >98 (59)    27 56 60:40 
14, 10 76 (94)   28[h] 88 [i] 
14, 11 93 (95)   29[h] 78 15:85 
14, 12 >98 (83) 30[h] 47 [i] 
15, 9 90 (93) 21[f] 34[g] 65:35 
15, 10 70[d]    31 60 >98:<2 
16, 9 97[d] 32 88 >98:<2 
16, 10 95[d] 33 75 >98:<2 
16, 11 93[d] 34  61 >98:<2 
16, 12 >98[d] 35  98 70:30 
17, 9 92[d] 36  76 25:75 
17, 10 90[d]  37  78 70:30 
17, 12 99[d] 38 [j] 55 (E); 
15 (Z) 
 
[a] Method A: PPh3, DEAD, CH2Cl2 then F-SPE. [b] Mass recovery (and purity 
determined by 500 MHz 1H NMR spectroscopy) after purification by F-SPE 
alone.  [c] Method C: 2 or 5 mol% Hoveyda-Grubbs second generation catalyst, 
0, 4 or 10 mol% 1,4-benzoquinone, MTBE, 55 C then P(CH2OH)3, Et3N, silica 
(see Supporting Information). [d] Yield after column chromatography.  [e] 
Determined by 500 MHz 1H NMR spectroscopy.  [f] The product had 
R1=FDIPES; R2=R3=H after desulfonylation. [g] Yield over two steps after 
desulfoylation with PhSH, K2CO3. [h] The geometric isomers were separable 
after subsequent desulfonylation. [i] Not determined at this stage; after 
desulfonylation, 28 and 30 were separable geometric isomers.  [j] The 
geometrical isomers were separable. 
 
Figure 3. Macrocycle size and natural product-likeness scores of the 17 
deprotected macrocyclic scaffolds prepared (black dots) and 2435 
commercially-available macrocycles (blue dots).   
               
Scheme 4. Exemplar decoration of a macrocyclic scaffold.  Method D: 
PhSH, K2CO3; Method E: urea or sulfonamide formation; Method F: 50% 
aq. HF, CH2Cl2MeCN then Me3SiOMe. 
To demonstrate biological relevance, the antimycobacterial 
activity of the 66 decorated macrocyclic products was assessed 
using Mycobacterium bovis BCG, a model organism for 
Mycobacterium tuberculosis (Supporting Information). In each 
case, the bacterium was cultured in the presence of 20 M 
macrocycle, and cell viability was assessed by the ability of 
metabolically-active cells to reduce non-fluorescent resazurin to 
fluorescent resorufin.[21]  Under these conditions, the macrocycle 
39a had significant activity, causing 80% growth inhibition.[22]  
The IC50 of the macrocycle 39a (IC50 = 11 M) was determined, 
together with those of a range of analogues: 39b and 39c which 
bear different substituents (IC50 = 35 and 30 M respectively); 
the isomeric meta cyclophane 40a (IC50 = 21 M); and the ring-
contracted analogue 41a (IC50 = 24 M) (Figure 4).  Taken 
together, the initial single concentration and subsequent 
concentration-dependent activity determinations suggest that 
both the macrocyclic scaffold and the substituents are important 
for biological function.  Hits from such phenotypic screens are 
highly valuable since they can facilitate the identification of new 
targets for antimycobacterial drug discovery.[23]  Crucially, the 
macrocycle 39a is highly distinctive from the TB box set secured 
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from a high-throughput screen of GSK’s collection:[24] none of 
the 177 compounds in the box set contains a macrocyclic ring.   
A 
 
      
Figure 4. Effect of macrocycles on the viability of M. bovis BCG.  Panel 
A: Dose-dependent activity of the macrocycle 39a and four analogues.  
Panel B: Antimycobacterial activity of selected macrocycles.   
In summary, we have developed a modular approach that was 
exploited in the synthesis of 17 diverse natural product-like 
macrocyclic scaffolds.  Through variation of the triplets of 
building blocks used, systematic variation of the scaffolds and 
macrocyclic ring size (12-20-membered) was possible.  The 
biological relevance of chemical space explored was 
demonstrated through discovery of a series of distinctive 
macrocycles with significant antimycobacterial activity.  
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